GIL ZALSMAN, MD
Update November17th, 2011
LIST OF PUBLICATIONS
B.1. ORIGINAL ARTICLES
1.Zalsman G,Aizenberg D, Sigler M, Nahshoni E, Weizman A
Geriatric Depression Scale-Short Form. Validity and Reliabiity of the
Hebrew Version
Clinical Gerontologist 1998; 18(3):3-9
2.Zalsman G, Aizenberg D, Sigler M, Nahshony E, Karp L, Weizman A.
Increased risk for dementia in elderly psychiatric inpatients with late-onset major depression.
J Nerv Ment Dis. 2000 Apr;188(4):242-3.
3.Zalsman G, Netanel R, Fischel T, Freudenstein O, Landau E, Orbach I, Weizman A, Pfeffer CR, Apter A.
Human figure drawings in the evaluation of severe adolescent suicidal behavior.
J Am Acad Child Adolesc Psychiatry. 2000 Aug;39(8):1024-31.
4.Horesh N, Zalsman G, Apter A.
Internalized anger, self-control, and mastery experience in inpatient anorexic adolescents.
J Psychosom Res. 2000 Oct;49(4):247-53
5.Zalsman G, Horesh N, Arzi R, Edelist D, Har Even D, Tyano S, Poustka F, Apter A.
Psychosocial diagnosis in psychiatrically hospitalized adolescents.
Compr Psychiatry. 2001 May-Jun;42(3):223-7.
6.Zalsman G, Frisch A, Bromberg M, Gelernter J, Michaelovsky E, Campino A, Erlich Z, Tyano S, Apter A, Weizman A.
Family-based association study of serotonin transporter promoter in suicidal adolescents: no association with suicidality but possible role in violence traits.
Am J Med Genet. 2001 Apr 8;105(3):239-45.
7.Nahshoni E, Aizenberg D, Sigler M, Zalsman G, Strasberg B, Imbar S, Weizman A.
Heart rate variability in elderly patients before and after electroconvulsive therapy.
Am J Geriatr Psychiatry. 2001 Summer;9(3):255-60.
8.Zalsman G, Weizman A, CarelCA, Aizenberg D.
Geriatric Depression Scale (GDS-15): a sensitive and convenient instrument for measuring depression in young anorexic patients.
J Nerv Ment Dis. 2001 May;189(5):338-9.
9.Zalsman G, Frisch A, King RA, Pauls DL, Grice DE, Gelernter J, Alsobrook J, Michaelovsky E, Apter A, Tyano S, Weizman A, Leckman JF.
Case control and family-based studies of tryptophan hydroxylase gene A218C polymorphism and suicidality in adolescents.
Am J Med Genet. 2001 Jul 8;105(5):451-7.
10.Valevski A, Ratzoni G, Sever J, Apter A, Zalsman G, Shiloh R, Weizman A, Tyano S.
Stability of diagnosis: a 20-year retrospective cohort study of Israeli psychiatric adolescent inpatients.
J Adolesc. 2001 Oct;24(5):625-33.
11.Gothelf D, Falk B, Singer P, Kairi M, Phillip M, Zigel L, Poraz I, Frishman S, Constantini N, Zalsman G, Weizman A, Apter A.
Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine.
Am J Psychiatry. 2002 Jun;159(6):1055-7.
12.Hermesh H, Weizman A, Gur S, Zalsman G, Shiloh R, Zohar J, Gross-Isseroff R.
Alternation learning in OCD/schizophrenia patients.
Eur Neuropsychopharmacol. 2003 Mar;13(2):87-91.
13.Zalsman G, Carmon E, Martin A, Bensason D, Weizman A, Tyano S.
Effectiveness, safety, and tolerability of risperidone in adolescents with schizophrenia: an open-label study.
J Child Adolesc Psychopharmacol. 2003 Fall;13(3):319-27
14.Zalsman G, Frisch A, Lev-Ran S, Martin A, Michaelovsky E, Bensason D, Gothelf D, Nahshoni E, Tyano S, Weizman A.
DRD4 exon III polymorphism and response to risperidone in Israeli adolescents with schizophrenia: a pilot pharmacogenetic study.
Eur Neuropsychopharmacol. 2003 May;13(3):183-5.
15.Apter A, Horesh N, Gothelf D, Zalsman G, Erlich Z, Soreni N, Weizman A.
Depression and suicidal behavior in adolescent inpatients with obsessive compulsive disorder.
J Affect Disord. 2003 Jul;75(2):181-9.
16.Nahshoni E, Aizenberg D, Sigler M, Strasberg B, Zalsman G, Imbar S, Adler E, Weizman A.
Heart rate variability increases in elderly depressed patients who respond to electroconvulsive therapy.
J Psychosom Res. 2004 Jan;56(1):89-94.
17.Zalsman G, Pumeranz O, Peretz G, Ben-Dor DH, Dekel S, Horesh N, Fischel T, Nahshoni E, Goldberg PH, Sever J, Apter A.
Attention patterns in children with attention deficit disorder with or without hyperactivity.
ScientificWorldJournal. 2003 Nov 13;3:1093-107.
18.Nahshoni E, Manor N, Bar F, Stryjer R, Zalsman G, Weizman A.
Alterations in QT dispersion in medicated schizophrenia patients following electroconvulsive therapy.
Eur Neuropsychopharmacol. 2004 Mar;14(2):121-5.
19.Nahshoni E, Aravot D, Aizenberg D, Sigler M, Zalsman G, Strasberg B, Imbar S, Adler E, Weizman A.
Heart rate variability in patients with major depression.
Psychosomatics. 2004 Mar-Apr;45(2):129-34.
20.Zalsman G, Huang YY, Harkavy-Friedman JM, Oquendo MA, Ellis SP, Mann JJ.
Relationship of MAO-A promoter (-VNTR) and COMT (V158M) gene polymorphisms to CSF monoamine metabolites levels in a psychiatric sample of caucasians: A preliminary report.
Am J Med Genet B Neuropsychiatr Genet. 2005 Jan 5;132(1):100-3.
21.Huang YY, Battistuzzi C, Oquendo MA, Harkavy-Friedman J, Greenhill L, Zalsman G, Brodsky B, Arango V, Brent DA, Mann JJ.
Human 5-HT1A receptor C(-1019)G polymorphism and psychopathology.
Int J Neuropsychopharmacol. 2004 Dec;7(4):441-51.
22.Zalsman G, Posmanik S, Fischel T, Horesh N, Gothelf D, Gal G, Sadeh A, Weizman A, Apter A.
Psychosocial situations, quality of depression and schizophrenia in adolescents.
Psychiatry Res. 2004 Dec 15;129(2):149-57.
23.Zalsman G, Frisch A, Lewis R, Michaelovsky E, Hermesh H, Sher L, Nahshoni E, Wolovik L, Tyano S, Apter A, Weizman R, Weizman A.
DRD4 receptor gene exon III polymorphism in inpatient suicidal adolescents.
J Neural Transm. 2004 Dec;111(12):1593-603.
24.Khait VD, Huang YY, Zalsman G, Oquendo MA, Brent DA, Harkavy-Friedman JM, Mann JJ.
Association of serotonin 5-HT2A receptor binding and the T102C polymorphism in depressed and healthy Caucasian subjects.
Neuropsychopharmacology. 2005 Jan;30(1):166-72.
25.Horesh N, Zalsman G, Apter A.
Suicidal behavior and self-disclosure in adolescent psychiatric inpatients.
J Nerv Ment Dis. 2004 Dec;192(12):837-42.
26.Zalsman G, Anderson GM, Peskin M, Frisch A, King RA, Vekslerchik M, Sommerfeld E, Michaelovsky E, Sher L, Weizman A, Apter A.
Relationships between serotonin transporter promoter polymorphism, platelet serotonin transporter binding and clinical phenotype in suicidal and non-suicidal adolescent inpatients.
J Neural Transm. 2005 Feb;112(2):309-15.
27.Sher L, Oquendo MA, Li S, Burke AK, Grunebaum MF, Zalsman G, Huang YY, Mann JJ.
Higher cerebrospinal fluid homovanillic acid levels in depressed patients with comorbid posttraumatic stress disorder.
Eur Neuropsychopharmacol. 2005 Mar;15(2):203-9.
28.Shoval G, Zalsman G, Polakevitch J, Shtein N, Sommerfeld E, Berger E, Apter A.
Effect of the broadcast of a television documentary about a teenager's suicide in Israel on suicidal behavior and methods.
Crisis. 2005;26(1):20-4.
29.Fennig S, Geva K, Zalsman G, Weizman A, Fennig S, Apter A.
Effect of gender on suicide attempters versus nonattempters in an adolescent inpatient unit.
Compr Psychiatry. 2005 Mar-Apr;46(2):90-7.
30.Sher L, Oquendo MA, Galfalvy HC, Grunebaum MF, Burke AK, Zalsman G, Mann JJ.
The relationship of aggression to suicidal behavior in depressed patients with a history of alcoholism.
Addict Behav. 2005 Jul;30(6):1144-53
31.Zalsman G, Molcho A, Huang Y, Dwork A, Li S, Mann JJ.
Postmortem -opioid receptor binding in suicide victims and controls.
J Neural Transm. 2005 Jul;112(7):949-54.
32.Zalsman G, Frisch A, Baruch-Movshovits R, Sher L, Michaelovsky E, King RA, Fischel T, Hermesh H, Goldberg P, Gorlyn M, Misgav S, Apter A, Tyano S, Weizman A.
Family-based association study of 5-HT(2A) receptor T102C polymorphism and suicidal behavior in Ashkenazi inpatient adolescents.
Int J Adolesc Med Health. 2005 Jul-Sep;17(3):231-8.
33.Zalsman G, Misgav S, Sommerfeld E, Kohn Y, Brunstein-Klomek A, Diller R, Sher L, Schwartz J, Shoval G, Ben-Dor DH, Wolovik L, Oquendo MA.
Children's Depression Inventory (CDI) and the Children's Depression Rating Scale-Revised (CDRS-R): reliability of the Hebrew version.
Int J Adolesc Med Health. 2005 Jul-Sep;17(3):255-7.
34.Turcin A, Turcin Z, Kumperscak HG, Zalsman G, Plesnicar BK.
Suicide attempts among adolescents in northeastern Slovenia: a 25 year report.
Int J Adolesc Med Health. 2005 Jul-Sep;17(3):259-65.
35.Brunstein-Klomek A, Orbach I, Meged S, Zalsman G.
Self complexity of suicidal adolescents.
Int J Adolesc Med Health. 2005 Jul-Sep;17(3):267-73.
36.Sher L, Oquendo MA, Galfalvy HC, Zalsman G, Cooper TB, Mann JJ.
Higher cortisol levels in spring and fall in patients with major depression.
Prog Neuropsychopharmacol Biol Psychiatry. 2005 May;29(4):529-34.
37.Sher L, Oquendo MA, Conason AH, Brent DA, Grunebaum MF, Zalsman G, Burke AK, Mann JJ.
Clinical features of depressed patients with or without a family history of alcoholism.
Acta Psychiatr Scand. 2005 Oct;112(4):266-71.
38.Tyano S, Zalsman G, Ofek H, Blum I, Apter A, Wolovik L, Sher L, Sommerfeld E, Harell D, Weizman A.
Plasma serotonin levels and suicidal behavior in adolescents.
Eur Neuropsychopharmacol. 2006 Jan;16(1):49-57.
39.Carballo JJ, Oquendo MA, Garcia-Moreno M, Poza B, Giner L, Baca E, Zalsman G, Roche AM, Sher L.
Demographic and clinical features of adolescents and young adults with
alcohol-related disorders admitted to the psychiatric emergency room.
Int J Adolesc Med Health. 2006 Jan-Mar;18(1):87-96.
40.Carballo JJ, Oquendo MA, Giner L, Garcia-Parajua P, Iglesias JJ, GoldbergPH, Zalsman G, Chaudhury SR, Sher L.
Prevalence of alcohol misuse among adolescents and young adults evaluated in aprimary care setting.
Int J Adolesc Med Health. 2006 Jan-Mar;18(1):197-202
41.Shoval G, Zalsman G, Sher L, Apter A, Weizman A.
Clinical characteristics of inpatient adolescents with severe obsessive-compulsive disorder.
Depress Anxiety. 2006;23(2):62-70.
42.Schwartz-Stav O, Apter A, Zalsman G.
Depression, suicidal behavior and insight in adolescents with schizophrenia.
Eur Child Adolesc Psychiatry. 2006 Sep;15(6):352-9
43.Zalsman G, Hung YY, Oquendo MA, Burke AK, Hu XZ, Brent DA, Ellis SP, Goldman D, Mann JJ.
Association of a Triallelic Serotonin Transporter Gene Promoter region (5-HTTLPR), polymorphism with Stressful Life Events, and Severity of Depression.
Am J Psychiatry, 2005 Sep;163(9):1588-93
44.Sher L, Carballo JJ, Grunebaum MF, Burke AK, Zalsman G, Huang YY, Mann JJ, Ocquendo MA
A prospective study of the association of cerebrospinal fluid monoamine metabolite levels with lethality of suicide attempts in patients with bipolar disorder
Bipolar Disorders2006,8(5):543-550
45.Zalsman G, Braun M, Grunebaum MF, Sher L, Burke AK, Brent, DA, Chaudhury SR, Mann JJ, Oquendo MA
A Comparison of Medical Lethality of Suicide Attempts
among Subjects with Bipolar and Major Depressive Disorders
Bipolar Disord 2006,8(5):558-565
46.Shoval G, Sever J, Sher L, , Diller R, Apter A, Weizman A,Zalsman G
Substance use, Suicidality and Adolescent-onset Schizophrenia-an Israeli Ten-year Retrospective Study
J Child Adolesc Psychopharmacol 2006, 16(6):767-775
47.Shoval G, Zalsman G, Nahshoni E, Weizman A
The use of Illicit substances in adolescent schizophrenia inpatients
Int J. Adolesc Med Health 2006; 18(4):643-648
48.Shoval G, Zalsman G, Apter A, Diller R, Sher L, Weizman A.
A ten years retrospective study of inpatient adolescents with schizophrenia/schizoaffective disorders and substance use.
Compr Psychiatry. 2007 48(1):1-7
49.Brunstein-Klomek A, Zalsman G, Apter A, Meged S, Har Even D, Diller R, Orbach I.
Self-Object Differentiation in Suicidal Adolescents.
Compr Psychiatry. 2007 48(1):8-13
50.Nahshoni E, Shpitzer S, Berant M, Shoval G, Zalsman G, Weizman A
QT interval and dispersion in very young children treated with antipsychotic drugs: A retrospective chart review
J Child Adolesc Psychopharmacol 2007 17(2):187-194
51.Sher L, Sperling D, Stanley BH, Carballo JJ, Shoval G, Zalsman G, Burke AK, Mann JJ and Oquendo MA
Triggers for suicidal behavior in depressed older adolescents and young adults: Do alcohol use disorders make a difference?
Int J. Adolesc Med Health 2007;19(1) 91-98
52.Wilson ST, Stanley B, Oquendo MA, Goldberg P, Zalsman G, Mann JJ
Comparing Impulsiveness, Hostility and depression in Borderline Personality Disorder and Bipolar II Disorder
J Clin Psychiatry 2007 (68) 10:1533-1539
53.Gothelf D, Aviram-Goldring, A, Burg M, Steinberg T, Mahajnah M, Frisch A, Fennig S, Zalsman G,Weizman A
Cognition, psychosocial adjustment and coping in familial cases of velocardiofacial syndrome
J Neural Transm2007;114(11):1495-1501 (Neuroscience 106/231 IF=2.25)
54.Arie M, Apter A, Orbach I, Yefet Y, Zalsman G
Autobiographical Memory, Interpersonal Problem solving and Suicidal Behavior in Adolescent Inpatients
Compr Psychiatry 2008;49(1):22-9(Psychiatry 63/117IF=2.08)
55.Klomek AB, Orbach I, Sher L, Sommerfeld E, Diller R, Apter A, Shahar G, Zalsman G
Quality of Depression among Suicidal Inpatient Youth.
Arch Suicide Res 2008;12(2):133-40.
56.Golubchik P, Sever J, Zalsman G, Weizman A
Methylphenidate in the treatment of female adolescents with cooccurrence of attention deficit/hyperactivity disorder and borderline personality disorder: a preliminary open-label trial
Int Clin Psychopharmacol 2008: 23(4):228-31 (PSYCHIATRY 38/117 IF=3.34)
57.Manor I, Meidad S, Zalsman G, Zemishlany Z, Tyano S, Weizman A Objective Versus Subjective Assessment of Methylphenidate Response.
Child Psychiatry Hum Dev2008 39(3):273-82(SOCIAL SCIENCES/PSYCHIATRY 48/94 IF=1.53)
58.Gorlyn M, Keilp JG, Grunbaum MF, Taylor BP, Oquendo MA, Bruder GE, Stewart JW, Zalsman G, Mann JJ
Neuropsychological Characteristics as Predictors of SSRI Treatment Response in Depressed Subjects
J Neural Transm 2008 115(8):1213-9 (Neuroscience 106/231 IF=2.25)
59.Zalsman G, Huang Y, Oquendo MA, Brent DA, Giner L, Haghighi F, Burk AK, Ellis SP, Currier D, Mann JJ
No association of COMT Val158Met polymorphism with suicidal behavior or CSF monoamine metabolites in mood disorders
Arch Suicide Res 2008 12(4):327-35
60.Zalsman G, Mann MJ, Huang YY, Oquendo A, Brent DA, Burke AK, Ellis SP, Mann JJ
Wolfram Syndrome 1(WFSI) H611R Polymorphism is Associated with Mood Disorders but not Suicidal Behavior
Prog Neuropsychopharmacol Biol Psychiatry 2009 33(4):707-10. (PSYCHIATRY 43/117 IF=2.82)
61.Manor I, Gutnik I, Ben Dor DH, Apter A, Sever J, Tyano S, Weizman A, Zalsman G
The Possible Association between Attention Deficit Hyperactivity Disorder and Attempted Suicide in Adolescents – A Pilot Study
Eur Psychiatry2010 (3):146-50. (PSYCHIATRY 39/117 IF=3.08)
62.Nahshoni E, Sclarovsky s, Spitzer S, Zalsman G, Strasberg B, Weizman A
Early Repolarization in Young Children with ADHD versus normal Controls: A Retrospective Preliminary Chart Review
J Child Adolesc Psychopharmacol 2009 (6):731-5. (PSYCHIATRY 51/117 IF=2.59)
63.Zalsman G,Patya, M, Frisch A, Ofek, H, Schapir L, Blum, I, Harel D, Apter A, Weizman, A, Tyano, S
Association of Polymorphisms of the serotonergic pathways with clinical traits of impulsive-aggression and suicidality in adolescents: A multi-center Study
World J BiolPsychiatry 2011 (1):33-41 (PSYCHIATRY 8/117 IF=5.56)
64. Gilat Y, Ben-Dor DH, Magen A, Wolovick L, Vekslerchik M, Weizman A, Zalsman G
Trends in prescribing of psychotropic medications for inpatient adolescents in Israel: A ten years retrospective analysis
Eur Psychiatry 2011, 26(4); 265-269. (PSYCHIATRY 39/117 IF=3.08)
65.Freudenstein O, Zohar A, Apter A, Shoval G, Weizman A, Zalsman G,
Parental Bonding in Severely suicidal Adolescent Inpatients
Eur Psychiatry [Epub ahead of print].(PSYCHIATRY 39/117 IF=3.08)
66.Shoval G, Feld-Olspanger J, Nahshoni E, Gothelf D, Misgav S, Manor I, Apter A, Zalsman G
Suicidal Behavior and Related Traits among Inpatient Adolescents with First-Episode Schizophrenia
Comp Psychiatry [Epub ahead of print]. (PSYCHIATRY 63/117 IF=2.08)
67.Zalsman G, Rehavi M, Roz N, Laor N, Weizman A, Toren P
Altered Affinity of the platelet vesicular monoamine transporter 2 (VMAT2) in children with major depression
J Neural Transm 118(9); 1383-1387. (Neuroscience 106/231IF= 2.25)
68.Golubchik P, Sever J, Weizman A, Zalsman G
Methylphenidate treatment in pediatric patients with ADHD and co-morbid trichotillomania – a preliminary report
Clin Neuropharmacol 2011, 34:108-110 (pharmacology 53/237 IF=2.34)
69.Zalsman G,Aslanov-Farbstein D, Rehavi M, Roz N, Vermeiren R, Laor N, Weizman A, Toren P
Platelet vesicular monoamine transporter (VMAT2) density in non-ADHD disruptive disorder
J Child Adolesc Psychopharmacol2011; 21(4): 341-344 (PSYCHIATRY 51/117 IF= 2.59)
70.Manor I, Rozen S, Zemishlany Z, Weizman A, Zalsman G
When Does it end? ADHD in the middle aged and older populations
Clin Neuropharmacol 2011; 34(4):148-154
(pharmacology 53/237 IF=2.34)
71.Valevski A, Zalsman G, Tzafrir S, Lipschitz-Elhawi R, Haklai Z, Weizman A, Shohat T
Rate of readmission and mortality risks of schizophrenia patients who were discharged against medical advice
Eur Psychiatry [Epub ahead of print] (PSYCHIATRY 39/117 IF=3.08)
72.Horesh N, Apter A, Zalsman G,
Timing. Quantity and quality of stressful life events in childhood and preceding the first episode of bipolar disorder
J Affect Disord 2011;134(1-3): 434-437 (PSYCHIATRY 27/117 IF=3.76)
73.Leibovich V, Keilikhis Y, Barzilay A, Cohen D, Shoval G, Schapir L, Libman A, Shemesh R, Marcus I, Weizman A, Merrick J, Zalsman G
Level of training of nursing staff and the autonomy given to psychiatric inpatients: A multi center study
Int J Adolesc Med Health 2011;23(1) 45-50
74.Shoval G, Nahshoni E, Gothelf D, Manor I, Golobchik P, Zemishlany Z, Weizman A,Zalsman G
Effectiveness and safety of Citalopram in hospitalized adolescents with major depression – A preliminary, 8 week fixed-dose, open label, prospective study.
J Clin Psychopharmacology 2011; Sep 34(5):182-185 (pharmacology 53/237 IF=2.34)
75.Freudenstein O, Apter A, Zohar A, Shoval G, Nahshoni E, Weizman A, Zalsman G.
Perfectionism,Narcissism and depression in suicidal and non-suicidal adolescent inpatients.
Compr Psychiatry 2012, 53(6) :746-752. ( PSYCHIATRY 63/117 IF=2.08)
76.Manor I, Vurembrandt N, Rozen S, Gevah D, Weizman A, Zalsman G
Low self-awareness of ADHD in adults using a self-report screening questionnaire
Eur Psychiatry 2012 July 27 (5):314-320. (PSYCHIATRY 39/117 IF=3.08)
77.Galfalvy H*, Zalsman G*, Huang YY, Murphy L, Arango V, Mann JJ
A Pilot Genome-Wide Association and Gene Expression Array Study of Suicide with and without Major Depression
World J Biol Psychiatry2011 Nov 7 (PSYCHIATRY 8/117 IF=5.56)
*both authors contributed equally to this paper
78.Green T, Avda S, Dotan I, Zarchi O, Basel-vanagaite L, Zalsman G, Weizman A, Gothelf D.
Phenotypic psychiatric characterization of children with Williams Syndrome and response of those with ADHD to methylphenidate treatment
Am J Med GenetB (NPG) 2012 Jan 159b(1):13-20. ( PSYCHIATRY 35/117 IF=3.48).
79.Fennig S, Apter A, Horesh N, Arzi R, Zalsman G, Weizman A, Fennig S.
Relationship between ICD-10 psychosocial categories and psychiatric diagnosis inIsraeli adolescents. Isr J Psychiatry Relat Sci. 2011;48(2):111-6.
80.Nahshoni E, Golobchik P, Glazer J, Sever J, Strasberg B, Imbar S, Shoval G, Weizman A, Zalsman G
Late potentials in the signal-averaged electrocardiogram in pre-pubertal children with ADHD, before and after methylphenidate treatment.
Eur Child Adolesc Psychiatry2012 Feb 21(2):75-78. (PSYCHIATRY 71/117 IF=1.65)
81.Shoval G, Mansbach-Kleinfeld I, Farbstein I, Kanaaneh R, Lubin G, Krivoy A, Apter A, Weizman A, Zalsman G. The use of mental health services by adolescent smokers: A nationwide Israeli study. Eur Psychiatry. 2012 Apr 27.
82.Shoval G, Mansbach-Kleinfeld I, Farbstein I, Kanaaneh R, Lubin G, Apter A, Weizman A, Zalsman G. Self versus maternal reports of emotional and behavioral difficulties in suicidal and non-suicidal adolescents: An Israeli nationwide survey. Eur Psychiatry. 2012 Apr 27.
83.Shoval G, Manor I, Nahshoni E, Weizman A, Zalsman G. Are names of children with attention deficit hyperactivity disorder more 'hyperactive'?Psychopathology. 2012;45(4):215-9
84.Shoval G, Mansbach-Kleinfeld I, Farbstein I, Kanaaneh R, Valevski A, Apter A, Weizman A, Zalsman G. Gender differences in emotional and behavioral disordersand service use among adolescent smokers: A nationwide Israeli study. EurPsychiatry. 2012 Sep 19.
ACCEPTED FOR PUBLICATION
- Rotberg, B*, Kronenberg S., Carmel M., Frisch, A., Brent, D, Zalsman G, M.D., Apter A, Weizman, A. Additive Effects of 5-HTTLPR (Serotonin Transporter) and Tryptophan Hydroxylase-2 G-703T Gene Polymorphisms on the Clinical Response to Citalopram among Children and Adolescents with Depression and Anxiety Disorders.Journal of Child and Adolescent Psychopharmacology
SUBMITTED FOR PUBLICATION
B.2. CASE REPORTS
- Zalsman G, Hermesh H, Munitz H.
Alprazolam withdrawal delirium.
Clin Neuropharmacol, 1998; 21(3): 201-202. - Zalsman G, Cohen DJ.
Multiplex developmental disorder.
Isr J Psychiatry Relat Sci. 1998;35(4):300-6 - Zalsman G, Sever J, Munitz H.
Hair loss associated with paroxetine treatment: a case report.
Clin Neuropharmacol. 1999 Jul-Aug;22(4):246-7. - Zalsman G, Hermesh H, Sever J.
Hypnotherapy in adolescents with trichotillomania: three cases.
Am J Clin Hypn. 2001 Jul;44(1):63-8. - Zalsman G, Dror S, Gadoth N.
Hypnosis provoked pseudoseizures: a case report and literature review.
Am J Clin Hypn. 2002 Jul;45(1):47-53. - Zalsman G, Lewis R, Konas S, Loebstein O, Goldberg P, Burguillo F,Nahshoni E, Munitz H.
Atypical neuroleptic malignant syndrome associated with risperidone treatment in two adolescents.
Int J Adolesc Med Health. 2004 Apr-Jun;16(2):179-82.
B.3. REVIEW ARTICLES
- Feld J, Zalsman G, Apter A
Violence and homocide in psychotic patients
Harefua [Hebrew], 2001;140:51-54 - Gad A, Zalsman G, Tyano S.
Somatization disorder in children and adolescents
Harefua. 2002 Jan;141(1):39-43, 126. Hebrew. - Zalsman G, Frisch A, Apter A, Weizman A.
Genetics of suicidal behavior: candidate association genetic approach.
Isr J Psychiatry Relat Sci. 2002;39(4):252-61. Review. - Zalsman G, Shoval G
Nonpharmacological therapies for trichotillomania
Expert review of neurotherapeutics 2002 , 2(2): 212-216 - Portuguese S, Zalsman G.
Psychopharmacology of violent behavior in adolescents
Int J Adolesc Med Health 2003, 15 (3):191-200. - Pickholtz E, Zalsman G, Tyano S.
Volatile substance abuse in children and adolescents
Harefuah. 2003 Jun;142(6):459-63, 484. (Review. Hebrew. ) - Geva K, Zalsman G, Apter A
The influence of gender on risk factors for child and adolescent suicidal behavior]
Harefuah [Hebrew] 2003 ;142(3):203-207 - Abo A, Zalsman G
Terrorism and the adolescent population- a review
Int J Adolesc Med Health 2003 15 (3): 201-206. - Giner L, Nichols CM, Zalsman G, Oquendo MA.
Selective serotonin reuptake inhibitors and the risk for suicidality in
adolescents: an update.
Int J Adolesc Med Health. 2005 Jul-Sep;17(3):211-20. - Sher L, Zalsman G.
Alcohol and adolescent suicide.
Int J Adolesc Med Health. 2005 Jul-Sep;17(3):197-203. - Carballo JJ, Oquendo MA, Giner L, Zalsman G, Roche AM, Sher L,
Impulsive-aggressive traits and suicidal behaviour in adolescents and young adults with alcoholism
Int J Adolesc Med Health 2006;18(1):9-15. - Roche AM, Giner L, Zalsman G
Suicide in Early Childhood: A Brief Review
Int J Adolesc Med Health 2005; 17(3):00-00. - Carballo JJ, Oquendo MA, Garcia-Moreno M, Poza B, Giner L, Baca E, Zalsman G, Roche AM, Sher L
Alcohol related disorders, adolescents and the emergency room
Int J Adolesc Med Health (special issue)
July-Sept. Vol 17, No3, 2005 - Zalsman G, Brent DA, Weersing R
Depressive Disorders in childhood and Adolescents: An overview. Epidemiology, Clinical Manifestation and Risk Factors
Child Adolesc Psychiatric Clin N Am 2006;15(4) 827-842 - Zalsman G, Oquendo MA, Greenhill L, Goldberg PH, Kamali M, Martin A, Mann JJ
Neurobiology of depression in Children and Adolescents
Child Adolesc Psychiatric Clin N Am 2006;15(4) 843-868 - Brunstien-Klomek A, Zalsman G, Mufson L.
Interpersonal Psychotherapy for Depressed Adolescents (IPT-A)
Isr J Psychiatry Relat Sci. 2007;44(1):40-6. - Zalsman G, Birmaher B, Brent DA
Depression in children and adolescents
Harefua [Hebrew]
2006 Apr;145(4):286-91, 318. - Shoval G, Schoen G, Vardi N,Zalsman G,
Suicide in Ethiopian Immigrants in Israel: A Case for study of the Genetic-Environmental Relation in Suicide.
Archives of Suicide Research 2007 11(2)1-7 - Rotberg B, Schoen Gila, Zalsman G,
Anxiety Disorder in Children and Adolescence
Harefua [Hebrew]2008 147:628-633 - Rotberg B, Zalsman G, Weizman A
Obsessive Compulsive Disorder in children and adolescents
Harefua[Hebrew]2008 147:324-329 - Shani M, Levy M, Zalsman G
Challenges in nutrition-based treatment for weight control in adolescents suffering from schizophrenia[Hebrew]
Harefua[Hebrew] 2008;147(11):901-5, 939 - Schapir L, Zalsman G
Bipolar Disorder and Severe Mood Dysregulation in children and Adolescents
Harefua [Hebrew] 2008;147(6):526-31, 574 - Brukner Y, Manor I, Zalsman G
Disorders of Socialization in Children and Adolescents
Harefua [Hebrew]2009;148(2): 104-108 - Zalsman G, Levy T, Shoval G
Interaction of child and family psychopathology leading to suicidal behavior
PsychiatricClin N Am. 2008;31(2) :237-46(SOCIAL SCIENCES, PSYCHIATRY 40/94 IF =1.86) - Schlossberg K, Massler A, Zalsman G
Environmental Risk Factors for Psychopathology
Isr J Psychiatry Relat Sci2010:47(2):139-143 (IF=0.9) - Massler A, Zalsman G
Bipolar Disorder and Borderline Personality Disorders: Similarities and Differences
Harefuah [Hebrew]2011; 159:349-352
- Peskin M, Shpitzer S, Peleg T, Zalsman G.
Nosology, assessment and diagnosis of psychiatric disorders in early childhood. Harefua [Hebrew], 2011;150 (4): 353-358
- Schwartz-Lifshitz M, Zalsman G, Giner L, Oquendo MA. Can we really preventsuicide? Curr Psychiatry Rep. 2012 Dec;14(6):624-33.
- Wasserman D, Rihmer Z, Rujescu D, Sarchiapone M, Sokolowski M, Titelman D,Zalsman G, Zemishlany Z, Carli V. [The European Psychiatric Association (EPA)guidance on suicide treatment and prevention]. Neuropsychopharmacol Hung. 2012Jun;14(2):113-36. [ Hungarian].
- Amitai M, Peskin M, Gothelf D, Zalsman G. Autism spectrum disorders: updatesand new definitions. Harefuah. 2012 Mar;151(3):167-70, 188. [Hebrew].
32.Wasserman D, Rihmer Z, Rujescu D, Sarchiapone M, Sokolowski M, Titelman D,Zalsman G, Zemishlany Z, Carli V; European Psychiatric Association. The EuropeanPsychiatric Association (EPA) guidance on suicide treatment and prevention. Eur Psychiatry. 2012 Feb;27(2):129-41